{
  "id": 368,
  "text": "Endocervical sampling above the excisional bed to evaluate for residual disease is advised.A “top hat” endocervical excision to achieve the desired specimen length is not recommended.When concomitant AIS and CIN are diagnosed, management should proceed as per the recommendation of AIS.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Endocervical sampling above the excisional bed to evaluate for residual disease is advised.A “top hat” endocervical excision to achieve the desired specimen length is not recommended.When concomitant AIS and CIN are diagnosed, management should proceed as per the recommendation of AIS.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在同时诊断存在宫颈腺上皮内瘤变（AIS）和宫颈上皮内瘤变（CIN）时，治疗管理应优先按照AIS的推荐进行。根据规范，建议在切除组织床的上方进行宫颈管取样，以评估是否存在残留病变。然而，通常不建议通过“帽顶型”宫颈管切除术来获得更长的标本，因为该方法可能增加并发症风险且不显著改善病理评估效果。因此，在实际管理过程中，应以AIS的诊断为主导，综合患者实际情况制定治疗方案，同时密切监控病情发展以指导后续处理。",
  "query": "**在诊断同时存在AIS和CIN时，应如何指导治疗管理？**",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: **在诊断同时存在AIS和CIN时，应如何指导治疗管理？**\n\n<reference text>: Endocervical sampling above the excisional bed to evaluate for residual disease is advised.A “top hat” endocervical excision to achieve the desired specimen length is not recommended.When concomitant AIS and CIN are diagnosed, management should proceed as per the recommendation of AIS.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在同时诊断存在宫颈腺上皮内瘤变（AIS）和宫颈上皮内瘤变（CIN）时，治疗管理应优先按照AIS的推荐进行。根据规范，建议在切除组织床的上方进行宫颈管取样，以评估是否存在残留病变。然而，通常不建议通过“帽顶型”宫颈管切除术来获得更长的标本，因为该方法可能增加并发症风险且不显著改善病理评估效果。因此，在实际管理过程中，应以AIS的诊断为主导，综合患者实际情况制定治疗方案，同时密切监控病情发展以指导后续处理。"
}